These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15695377)

  • 1. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.
    Couch FJ; Johnson MR; Rabe K; Boardman L; McWilliams R; de Andrade M; Petersen G
    Cancer Res; 2005 Jan; 65(2):383-6. PubMed ID: 15695377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fanconi anemia gene mutations in young-onset pancreatic cancer.
    van der Heijden MS; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 2003 May; 63(10):2585-8. PubMed ID: 12750283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of FANCC and FANCG in familial pancreatic cancer.
    Rogers CD; van der Heijden MS; Brune K; Yeo CJ; Hruban RH; Kern SE; Goggins M
    Cancer Biol Ther; 2004 Feb; 3(2):167-9. PubMed ID: 14726700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
    van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
    Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.
    Gordon SM; Buchwald M
    Blood; 2003 Jul; 102(1):136-41. PubMed ID: 12649160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Fanconi anemia protein interactions by yeast two-hybrid analysis.
    Huber PA; Medhurst AL; Youssoufian H; Mathew CG
    Biochem Biophys Res Commun; 2000 Feb; 268(1):73-7. PubMed ID: 10652215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity.
    Kuang Y; Garcia-Higuera I; Moran A; Mondoux M; Digweed M; D'Andrea AD
    Blood; 2000 Sep; 96(5):1625-32. PubMed ID: 10961856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.
    Garcia-Higuera I; Kuang Y; Näf D; Wasik J; D'Andrea AD
    Mol Cell Biol; 1999 Jul; 19(7):4866-73. PubMed ID: 10373536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.
    Gallmeier E; Calhoun ES; Rago C; Brody JR; Cunningham SC; Hucl T; Gorospe M; Kohli M; Lengauer C; Kern SE
    Gastroenterology; 2006 Jun; 130(7):2145-54. PubMed ID: 16762635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.
    van der Heijden MS; Brody JR; Dezentje DA; Gallmeier E; Cunningham SC; Swartz MJ; DeMarzo AM; Offerhaus GJ; Isacoff WH; Hruban RH; Kern SE
    Clin Cancer Res; 2005 Oct; 11(20):7508-15. PubMed ID: 16243825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system.
    Reuter T; Herterich S; Bernhard O; Hoehn H; Gross HJ
    Blood; 2000 Jan; 95(2):719-20. PubMed ID: 10627486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
    Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport.
    Reuter TY; Medhurst AL; Waisfisz Q; Zhi Y; Herterich S; Hoehn H; Gross HJ; Joenje H; Hoatlin ME; Mathew CG; Huber PA
    Exp Cell Res; 2003 Oct; 289(2):211-21. PubMed ID: 14499622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.
    Qiao F; Moss A; Kupfer GM
    J Biol Chem; 2001 Jun; 276(26):23391-6. PubMed ID: 11297559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
    Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
    Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.